Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics for intestinal microecology reconstruction in ulcerative colitis
ChiCTR-IPR-17010306Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of Inner Mongolia Medical University
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Salcrozine in autoimmune colitis (4 arms), sponsored by Affiliated Hospital of Inner Mongolia Medical University. Primary endpoints: Microbial phylum-level relative abundance, Microbial genus-level relative abundance and 1 more. Planned start Feb 2017; status: not yet recruiting.
02
Drugs
Salcrozine
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on ChiCTR-IPR-17010306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010306.